Publication | Open Access

Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trial

Thyroid TumoursMedicineMetronomic TherapyPathologyTumour-agnostic EfficacyCancer TreatmentBasket TrialOncologyRadiation OncologyCancer ResearchRadiologyHealth Sciences